ID   BexBra4
AC   CVCL_VP40
DR   Wikidata; Q93425714
RX   PubMed=19915932;
CC   Doubling time: 43 hours (PubMed=19915932).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=19915932
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,14
ST   D16S539: 9,12
ST   D18S51: 13,17
ST   D19S433: 15,16.2
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 17,18
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 6,9.3
ST   TPOX: 9,10
ST   vWA: 14,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=19915932; DOI=10.1007/s11626-009-9252-z;
RA   Piantino, Camila Belfort
RA   Sousa-Canavez, Juliana Moreira
RA   Srougi, Victor
RA   Salvadori, Fernanda A.
RA   Kato, Raphael B.
RA   Ayres, Pedro Paulo R.
RA   Srougi, Miguel
RA   Camara-Lopes, Luiz Heraldo
RA   Gattas, Gilka Jorge Figaro
RA   Fridman, Cintia
RA   de Toledo Goncalves, Fernanda
RA   Santana, Isabel
RA   Leite, Katia Ramos Moreira
RT   "Establishment and characterization of human bladder cancer cell lines
RT   BexBra1, BexBra2, and BexBra4.";
RL   In Vitro Cell. Dev. Biol. Anim. 46:131-139(2010).
//